Dr. Martens said trading since the start of the current financial year has been in line with expectations and its outlook and guidance for fiscal 2027 are unchanged. The company noted it is on track with strategic objectives for the year, with its largest market, the USA, continuing to grow and wholesale particularly encouraging. Japan and South Korea, its largest Asian markets, are both performing well, while European markets are performing as expected against a challenging consumer backdrop.
Dr. Martens PLCTrading in line with expectations, USA growing, wholesale encouraging, Asia performing well.